Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Taura syndrome wikipedia , lookup
Foot-and-mouth disease wikipedia , lookup
Hepatitis C wikipedia , lookup
Human cytomegalovirus wikipedia , lookup
Orthohantavirus wikipedia , lookup
Hepatitis B wikipedia , lookup
Marburg virus disease wikipedia , lookup
Canine parvovirus wikipedia , lookup
West Nile fever wikipedia , lookup
Canine distemper wikipedia , lookup
Henipavirus wikipedia , lookup
Micribiology: CNS Infections (Holland) DNA VIRUSES AND CNS INFECTIONS: Herpesvirus: Herpesvirus Infections of the CNS: HSV Encephalitis: o Basics: most common form of sporadic fatal encephalitis in aduse o Pathogenesis: focal encephalopathy, most often affecting the temporal lobe o Symptoms: fever, altered consciousness and behavior, severe headache, disordered thinking, LOC o Mortality: very high if not treated o Treatment: Acyclovir and other anti-herpesviral drugs (reduce mortality) Note: many patients do NOT regain full mental function (long term sequelae) even with treatment Herpes B Virus (Cercopithecine Herpesvirus 1) Infections: o Basics: monkey virus o Transmission: infected animals secrete virus in saliva and other bodily secretions (may not appear sick); therefore, transmitted by bite or contact of secretions with mucous membranes o Mortality: highly pathogenic for humans with high frequency of fatal encephalitis o Treatment: high doses of acyclovir/ganciclovir (but often also long term sequelae) VZV Infections: o Complications of Varicella: Encephalitis (most common of these but still fairly uncommon) Transient cerebellar ataxia (usually self-limiting) Aseptic meningitis (rare) Transverse myelitis (rare; infection of the spinal cord) o Complications of Zoster: Encephalitis o Congenital Varicella: Mental retardation Cerebral atrophy Non-CNS abnormalities Congenital CMV Infections: o Mechanism: transplacental transmission of CMV during primary infection of mother o Presentation: Some (~10%) Present with Signs at Birth: Intrauterine growth retardation Hepatosplenomegaly Microcephaly (long term neurological issues) Many develop long term sequelae: mental retardation, seizures, blindness, deafness, or death The rest are asymptomatic at birth: have a significant probability (10-15%) of developing hearing and vision problems, as well as intellectual impairment Polyomavirus: Human Polyomavirus: Basics: o Family: Papoviridae o Subfamily: Polyomavirinae Types Endemic in Humans: o JC Virus: asymptomatic in most cases, but can be associated with mild URI Associated with Progressive Multifocal Leukoencephalopathy (PML) o BK Virus: may cause a mild URI Associated with polymavirus nephropathy in renal transplant patients Associated with hemorrhagic cystitis in bone marrow transplant patients Newly Discovered: o KI Virus o WU Virus o MCV (Merkel Cell Virus) Animal Polyomaviruses: Polymavirus: mouse virus that causes multiple types of tumors in mice SV40: monkey virus closely related to JCV and BKV; reported to have been isolated from some human tumors (although role in human cancer is controversial) Characteristic of Polyomavirus: Structure: nonenveloped icosahedral Genome: circular, dsDNA Replication: in the nucleus; highly dependent on cellular enzymes for DNA replication and gene expression JC Virus: Basics: prevalent word-wide with 50-75% of adults being seropositive Transmission: mode unknown Primary Infections: frequently asymptomatic (may be associated with mild URI) Progressive Multifocal Leukoencephalopathy in Immunocompromise: o Clinical Features: Initial Symptoms: usually indicate focal cerebral involvement (personality changes, intellectual development, loss of motor skills, sensory loss) Less Frequently: symptoms may indicate cerebellar or brain stem involvement (difficulty speaking, swallowing, ataxia) Rapid Progression: death occurs within 2-12 months Treatment: generally not treatable; rare remissions may occur, associated with correction of immunodeficiency o Pathogenesis: Pathological changes may occur in the cerebrum, cerebellum or brain stem Lesions characterized by loss of myelin Cerebrum: this typically occurs in the subcortical regions (deep white matter) as opposed to the cerebral cortex and gray matter, which appear normal Loss of myelin is due to virus replication in oligodendrocytes Little to no inflammation* o Diagnosis: Suspicion: should be suspected in immunocompromised patients with progressive development of neurological deficits Imaging: MRI/CT for lesions in subcortical and deep white matter PCR: detection of JCV in CSF Brain Biopsy: verify presence of JCV and eliminate other infections that may imitate PML (ie. Toxoplasma gondii, Cryptococcus neoformans, Mycobacterium tuberculosis TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES: TSE Basics: Basics: invariably fatal neurodegenerative diseases Infectious Agent: prion (infectious protein) Transmission of TSE: ingestion or inoculation Spontaneous Occurrence of TSE: sporadic or familial Basic Characteristics: Clinical: o Impaired cognitive function o Ataxia o Progressive degeneration of neurological function leading to death Histological: o Spongiform degeneration o Amyloid plaques o Activated astrocytes and microglial cells Molecular: o Accumulation of an abnormal, protease-resistant form of PRNP gene product o PRNP Gene: Present in all vertebrates PrPc (cellular) or PrPsen (protease sensitive) is the normal form PrPsc (scrapie) or PrPres (protease resistance) is the abnormal form o PrPc vs. PrPsc: both have the same amino acid sequence but different conformations PrPc: membrane bound glycoprotein with high alpha-helix content PrPsc: primarily beta-sheet configuration Characteristics of Human TSEs: Prion Disease sCJD Major Symptoms Dementia Ataxia Myoclonus Visual problems Similar to sCJD Major CNS Target Cerebrum 6 month Similar to sCJD Cerebrum 26 (12-74) 14 months (6-24 months) Cerebrum Gerstmann-StrausslerScheinker Syndrome (GSS) 50-60 5-6 years (3 months-13 yr) Fatal Familial Insomnia (FFI) Only affects a few families 50 (20-63) 13-15 months (6-42 months) Psychiatric symptoms Neurological deficits Cognitive decline Cerebellar dysfunction Ataxia Nystagmus Dysarthria Insomnia Autonomic disorders fCJD Mutation in PRNP gene leads to predisposition iCJD Due to medical procedure or neurosurgery instruments vCJD Age at Onset 55-70 (17-83) Disease Duration 6 months (1-35 months) 50-60 6 months (2-41 months) Any age Cerebrum Cerebellum Thalamic involvment Creutzfeldt-Jakob Disease (CJD): Basics: most common TSE affecting humans Forms: o Sporadic (sCJD): no identified cause o Familial (fCJD): autosomal dominant mutations in PRNP, leading to predisposition o Iatrogenic (iCJD): neurosurgery, transplantation, brain-derived hormones (ie. hGH from cadavers) o Variant (vCJD): thought to be caused by transmission of BSE to humans Neuropathology: o Spongiform degeneration o Astrocytosis o Cerebral atrophy o Neuronal vacuolization (neurons killed) o Amyloid plaques o Lack of inflammation (due to the fact that there is NO immune response mounted) Molecular Aspects of Prions: Prion Replication Models: o Refolding Model: exposure of PrPc to PrPsc converts PrPc to PrPsc (exposure of normal to abnormal converts normal to more abnormal) PrPc does not spontaneously convert to PrPsc (or vice vers) Exception: hereditary TSE disease (mutant forms of PrPc may spontaneously convert) o Seeding (Nucleation) Model: PrPc and PrPsc are in equilibrium with eachother (balance strongly favors PrPc) PrPsc slowly form aggregates (since rate is so low, it almost never happens spontaneously) In this model, there is a little PrPsc around all the time Prion Strain Variation: o Prions derived from different sources exhibit different properties : variation in disease symptoms and pathology Localization: cerebrum vs. cerebellum Disease time course Extend of amyloid protein deposition Ease of crossing species barriers o Variation at the molecular level: Prion conformation Extent of glycosylation PRNP Gene: Genotype Influences Susceptibility to Disease: o PRNP Codon 129: can be MM, MV, or VV Normal Population: most are MV Sporadic CJD: most are MM Variant CJD: all are MM Mutations in PRNP Gene: o Pathogenic octarepeat insertions can be deleted and may segregate with a neurogenenerative disorder Bovine Spongiform Encephalitis (Mad Cow Disease): Origin Theories: o BSE comes from a Scrapie (TSE of sheep): Previously thought to be non-transmissible to other animals Sheep and cattle waste parts used to make meat and bone meal added to animal feed, which may have transferred disease to cattle through feed (crossing “species barrier”) o BSE comes from spontaneous conformational shift of bovine PrP: which then spread to other cattle through contaminated feed vCJD and BSE: vCJD may originate from BSE: o Early clinical onset and neuropathology distinct from other forms of CJD o Protease Fingerprinting shows vCJD prions resemble BSE prions, not classical CJD prions (strongly suggests transmission from cattle) Full scope of human outbreak hard to estimate: o Best Case: a few hundred cases This is the prediction of BSE is hard to transmit to humans Current cases would mostly result from those infected at the peak of the BSE epidemic in cattle (ie. only a few were infected when exposure was highest- can expect a decrease in number of cases) o Worst Case: several tens of thousands of cases This is the prediction if current cases were infected at the beginning of BSE epidemic (before exposure was the highest- therefore, in the next few years, you would expect the number of cases to increase)